Springer Nature

Yili Innovation Center Europe Kicks Off All-round Upgrades

Retrieved on: 
星期一, 四月 22, 2024

At the ceremony, Liu Chunxi, Executive President of Yili Group, introduced how the Group collaborated with partners from upstream and downstream segments in global industrial supply chains for years to strive for innovation.

Key Points: 
  • At the ceremony, Liu Chunxi, Executive President of Yili Group, introduced how the Group collaborated with partners from upstream and downstream segments in global industrial supply chains for years to strive for innovation.
  • At the site, YICE released ten major innovation achievements, covering areas such as breast milk research, probioticsdevelopment, cheese innovation, sugar reduction, food safety, and the development and application of AI technology products.
  • I'm looking forward to continuing this collaboration with Yili with its open spirit for collaboration with colleagues, academics, and their drive for innovation. "
  • The latest scientific research achievements of the European Center of the National Center of Technology Innovation for Dairy also made their debut at the event site.

Yili Innovation Center Europe Kicks Off All-round Upgrades

Retrieved on: 
星期一, 四月 22, 2024

At the ceremony, Liu Chunxi, Executive President of Yili Group, introduced how the Group collaborated with partners from upstream and downstream segments in global industrial supply chains for years to strive for innovation.

Key Points: 
  • At the ceremony, Liu Chunxi, Executive President of Yili Group, introduced how the Group collaborated with partners from upstream and downstream segments in global industrial supply chains for years to strive for innovation.
  • At the site, YICE released ten major innovation achievements, covering areas such as breast milk research, probioticsdevelopment, cheese innovation, sugar reduction, food safety, and the development and application of AI technology products.
  • I'm looking forward to continuing this collaboration with Yili with its open spirit for collaboration with colleagues, academics, and their drive for innovation. "
  • The latest scientific research achievements of the European Center of the National Center of Technology Innovation for Dairy also made their debut at the event site.

Phytopathology Research Celebrates 100 Years of Plant Pathology Research in China

Retrieved on: 
星期四, 四月 18, 2024

BEIJING, April 18, 2024 /PRNewswire/ -- Plant pathology or phytopathology is a scientific study discipline focusing on plant diseases caused by pathogens and environmental factors. In China, the teaching of plant pathology commenced in 1910. Despite its relatively brief history, China's phytopathology research community has grown into a force to reckon with, contributing immensely to the body of scientific knowledge over 100 fruitful years—a feat that calls for celebrations!

Key Points: 
  • The esteemed journal published a special issue on plant pathology research in China, covering topics from plant diseases to immunity
    BEIJING, April 18, 2024 /PRNewswire/ -- Plant pathology or phytopathology is a scientific study discipline focusing on plant diseases caused by pathogens and environmental factors.
  • Accordingly, Phytopathology Research —a leading open-access journal from BioMed Central (part of Springer Nature) that publishes cutting-edge applied and fundamental plant pathology research—brought out a special issue, " Plant Pathology Research in China: A Centennial View ," on 6 April 2022.
  • Notably, the collection comprised comprehensive editorials and reviews about diverse topics related to plant pathology in the context of China.
  • Prof. Liu concludes, "The knowledge gained from plant pathology research has helped achieve sustainable agriculture in China, apart from its global impact."

A new measure of firm-level competition: an application to euro area banks

Retrieved on: 
星期四, 四月 18, 2024

Abstract

Key Points: 
    • Abstract
      This paper extends Boone (2008) by introducing a competition measure at the individual
      firm level rather than for an entire market segment.
    • We apply this extended Boone indicator to individual bank-level competition
      in the loan market in the four largest euro area countries and Austria.
    • Our new measure of firm-level competition enriches and complements
      other competition measures and provides a promising starting point for future market
      power analyses.
    • The only measure among non-structural measures that is based on the
      concept of competition as a process of rivalry is the Boone (2008) indicator.
    • We introduce
      a new performance measure of competition by extending the Boone indicator to the
      individual firm level.
    • Introduction
      The ability to reliably measure competition is valuable to researchers, analysts, and
      policymakers, especially antitrust authorities, financial supervisors, and central banks.
    • One broad
      category of indicators often used to measure competition are structural competition
      measures, such as static concentration measures, and dynamic measures, e.g., entry and
      exit rates.
    • Out of these measures, the only measure based on the
      concept of competition as a process of rivalry is the Boone indicator.
    • This study introduces a new performance measure of competition by extending the
      Boone indicator to the individual firm level.
    • It thus measures the
      increase in profits in percent of one percentage point increase in efficiency, with marginal
      costs as measure of efficiency.
    • We extend the theoretical
      underpinning of the measurement of competition for the entire market of Boone (2008) by
      a new measure of individual firm-level competition.
    • A concern of the literature is the gap
      between the practical application and the theoretical framework of Boone (2008).
    • We introduce within the same theoretical
      framework a new measure of competition on firm level, the MRP.
    • Our new
      measure significantly augments the antitrust evaluative framework by shedding light on
      whether a merger results in a less competitive market.
    • Our novel indicator focuses on
      firms? incentives to enhance their relative efficiency, as manifested in the elasticity
      between relative profits and efficiency.
    • However, an inefficient firm that is foreclosed could be more
      competitive than the larger efficient firm that relies on its scale economies.
    • Our new metric of competition unveils
      banks? ability to influence their profitability in the short term by cutting costs relative to
      their peers.
    • The new MRP indicator provides the ability to assess the impact
      of individual banks? competitiveness on their interest rate-setting behaviour in loan
      markets.
    • Incorporating this information promises a more refined understanding of the impact and
      timing of monetary policy rates changes on the real economy.
    • Section 3 introduces within the Boone
      (2008) theoretical framework our new measure of individual firm-level competition,
      including the interpretation of the MRP.
    • Section 4 provides an application of our new
      ECB Working Paper Series No 2925

      6

      individual firm-level competition measure to the loan market.

    • The StructureConduct-Performance paradigm (SCP) provides a traditional framework in the field of
      industrial organization for analysing competition behaviour in markets.
    • Concentrated
      markets ease the possibilities to collude implicitly or explicitly and therefore concentrated
      markets result in higher prices and profits.
    • For example, a tougher competition
      setup may lead to a reallocation of market shares, potentially forcing some firms to exit
      the market.
    • This approach gives firms? strategic behaviour
      central stage and focuses on the strategic interaction on prices and quantities, known as
      conjectural variation.
    • Another measure from
      this strand of literature is the H-statistic developed by Panzar and Rosse (1987).
    • The only competition measure from this performance literature where competition is the
      outcome from a process of rivalry is the Boone indicator.
    • A continuous and monotonically increasing relationship exists between
      RPD and the level of competition if firms are ranked by decreasing efficiency.
    • (2013) compare the Boone indicator with the price-cost margin
      and conclude that the profit elasticity is a more reliable measure of competition.
    • The high
      elasticity of profits to efficiency unequivocally indicates that the high market shares and
      therefore high profits are due to high efficiency.
    • A firm that quickly passes changes to the input prices is seen as a price
      taker with little market power.
    • Indicators of competition tend to measure different phenomenon and may provide
      conflicting messages, as reported for European banking by Carbo et al.
    • Application 2: Test the ?quiet life? and related market structure hypotheses using the
      MRP as competition or market structure measure.
    • Data
      Our application to individual bank-level competition in the euro area loan market uses
      balance sheet and income statement data from the Moody?s Analytics BankFocus for the
      calendar years 2013-2020.
    • As such, most publications
      on competition in the euro area includes the largest four member states.
    • Due to these restrictions the database was reduced to an unbalanced panel of up to 1862
      banks (depending on the year) from five euro area countries.
    • Application 1: Measure bank competition using MRP
      Looking at the distribution of the MRP for individual banks (Fig.
    • A similar finding for the four largest euro area countries as a group is
      reported in Carbo et al.
    • Application 2: Test of market structure hypotheses using MRP
      Our new measure of individual-bank competition can be used to test market structure
      theories.
    • Euro area banks? market power,
      lending channel and stability: the effects of negative policy rates, European Central Bank
      Working Paper, 2790 (February).
    • A
      new approach to measuring competition in the loan markets of the euro area, Applied
      Economics, 43 (23), 3155?3167.
    • Impact of bank competition on the interest rate pass-through in the euro area, Applied
      Economics, 45 (11), 1359?1380.

Springer Nature and the Breast Cancer Research Foundation Announce the Rising Scholars: Breast Cancer Program for Early Career Researchers

Retrieved on: 
星期二, 三月 26, 2024

Springer Nature and the Breast Cancer Research Foundation (BCRF) today announced the Rising Scholars: Breast Cancer program, a partnership between Nature Portfolio and BCRF which provides Early Career Researchers (ECRs) in the field of cancer with additional resources for professional development and career preparedness.

Key Points: 
  • Springer Nature and the Breast Cancer Research Foundation (BCRF) today announced the Rising Scholars: Breast Cancer program, a partnership between Nature Portfolio and BCRF which provides Early Career Researchers (ECRs) in the field of cancer with additional resources for professional development and career preparedness.
  • The Rising Scholars: Breast Cancer program is the result of over a decade of partnership between Springer Nature and BCRF.
  • BCRF has been a phenomenal and consistent partner for Springer Nature and was the first nonprofit to work with Springer Nature in adopting our data research solutions.
  • The new Rising Scholars: Breast Cancer program will provide concrete qualitative and quantitative data as to the impact of such endeavors going forward.

World Brain Mapping Foundation (WBMF) announced its 2024 award recipients holding its 21st Gathering for Cure (GFC) Awards Gala at the Historic Millenium Biltmore hotel in LA.

Retrieved on: 
星期二, 三月 12, 2024

LOS ANGELES, March 11, 2024 /PRNewswire/ -- The World Brain Mapping Foundation (WBMF) announced its 2024 award recipients and will hold the 21st Gathering for Cure (GFC) Awards Gala on Friday March 15, 2024 at former home to the Oscars, Millennium Biltmore Hotel in Los Angeles.

Key Points: 
  • LOS ANGELES, March 11, 2024 /PRNewswire/ -- The World Brain Mapping Foundation (WBMF) announced its 2024 award recipients and will hold the 21st Gathering for Cure (GFC) Awards Gala on Friday March 15, 2024 at former home to the Oscars, Millennium Biltmore Hotel in Los Angeles.
  • Joe Bolanos, Kevin Morris, George Perry, Dave Baron, and Ms. Ira Soebroto-Bullo (Golden Axon Leadership award) and Aysha Noor and Jemma Yoo (Student Service, Research and Leadership Award).
  • "Our award recipients are truly pioneers in their fields who have impacted millions of patients globally", said Dr. Babak Kateb, President of WBMF.
  • "GFC award is also aimed at raising funds for introducing new diagnostics and therapeutics for neurological disorders."

Deputy Minister of Ukraine, Nataliia Kalmykova, will be speaking at the LA Convention Center this week

Retrieved on: 
星期二, 三月 12, 2024

Deputy Minister of Ukraine, Nataliia Kalmykova, will be amongst keynotes ; Ukrainian neurosurgeons from the frontline will also be speaking about combat casualty care and participate in the convention in person.

Key Points: 
  • Deputy Minister of Ukraine, Nataliia Kalmykova, will be amongst keynotes ; Ukrainian neurosurgeons from the frontline will also be speaking about combat casualty care and participate in the convention in person.
  • Since the beginning of the war in Ukraine, SBMT has been supporting Ukrainian doctors with training and medical equipment.
  • The SBMT World Congress is renowned for its comprehensive program, offering a diverse range of presentations, hands-on workshops, Bioskills cadaver labs, and an expansive exhibition hall.
  • Attendees can expect to engage with cutting-edge research, innovative technologies, and expert insights that are shaping the future of neurosciences and neurotechnology.

Radcliffe Group Selects Springer Healthcare for Reprint Sales to Pharmaceutical Industry

Retrieved on: 
星期二, 三月 5, 2024

BOURNE END, England, March 5, 2024 /PRNewswire-PRWeb/ -- Today Radcliffe Group, which brings the latest and best science, information, and knowledge to cardiovascular clinicians around the world, announced it has chosen Springer Healthcare in an exclusive deal to handle its reprints to buyers in the pharmaceutical industry. The deal was facilitated by content licensing specialist MEI Global, LLC (MEIG), a leader in helping publishers create new revenue streams through strategic third-party partnerships.

Key Points: 
  • BOURNE END, England, March 5, 2024 /PRNewswire-PRWeb/ -- Today Radcliffe Group, which brings the latest and best science, information, and knowledge to cardiovascular clinicians around the world, announced it has chosen Springer Healthcare in an exclusive deal to handle its reprints to buyers in the pharmaceutical industry.
  • Jonathan McKenna, Managing Director of Radcliffe Cardiology, says "Radcliffe strives to equip healthcare professionals with the skills and practical insights they need to do their best for patients by bringing the world's cardiovascular knowledge to life.
  • We are excited about partnering with Springer Healthcare and leveraging their established connections in the pharmaceutical market to aide us in that goal."
  • "A number of discussions and negotiations for complementary redistribution deals are also underway, and we're excited to help Radcliffe expand the audience for this powerful medical research."

Launch of Ground-Breaking "Toward Good Simulation Practice" Book to Set New Standards in Biomedical Simulation

Retrieved on: 
星期一, 三月 4, 2024

CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.

Key Points: 
  • CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.
  • The book underscores the necessity for guidelines akin to the GxP standards, yet specifically tailored for in silico methodologies.
  • It leverages the ASMEV&V40 – 2018 standard as a model, proposing a consensus-driven framework to support CM&S with good practices applicable across the spectrum of medical solutions.
  • This partnership illustrates the proactive engagement between regulatory agencies and the scientific community to foster advancements in medical product development.

Launch of Ground-Breaking "Toward Good Simulation Practice" Book to Set New Standards in Biomedical Simulation

Retrieved on: 
星期一, 三月 4, 2024

CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.

Key Points: 
  • CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.
  • The book underscores the necessity for guidelines akin to the GxP standards, yet specifically tailored for in silico methodologies.
  • It leverages the ASMEV&V40 – 2018 standard as a model, proposing a consensus-driven framework to support CM&S with good practices applicable across the spectrum of medical solutions.
  • This partnership illustrates the proactive engagement between regulatory agencies and the scientific community to foster advancements in medical product development.